1,792 Results
Pharma Now releases Voices of Pharma podcast with GSK veteran Shyam Khante sharing leadership lessons, 5 pillars, and pharma transformation insights.
Team Pharma Now | Apr 04, 2026
Rhythm Pharmaceuticals appoints Kim Popovits to its Board as Ed Mathers steps down, strengthening leadership with commercialization expertise in rare neuroendocrine diseases.
Simantini Singh Deo | Apr 04, 2026
Denali Therapeutics takes full control of DNL593 after Takeda exits collaboration, advancing progranulin therapy for frontotemporal dementia with Phase 1/2 results expected by 2026.
Simantini Singh Deo | Apr 04, 2026
Abeona Therapeutics expands ZEVASKYN access with new Qualified Treatment Center in New York, supporting gene therapy delivery for epidermolysis bullosa patients
Simantini Singh Deo | Apr 03, 2026
Annovis Bio secures U.S. patent for buntanetap to prevent and treat infection-related brain injuries, expanding its neurodegenerative therapy program in Phase 3 development
Simantini Singh Deo | Apr 03, 2026
BioCardia submits CardiAMP HF clinical data to FDA to pursue accelerated approval pathway for its cell therapy in ischemic heart failure patients with reduced ejection fraction
Simantini Singh Deo | Apr 03, 2026
Biodexa Pharmaceuticals partners with Syngene International to manufacture MTX240 API and dosage form, supporting IND filing and Phase 1b/2a trial in GIST cancer
Simantini Singh Deo | Apr 03, 2026